share_log

Novo Nordisk's Wegovy Gets UK Approval as Preventative Treatment for Heart Problems in Obese, Overweight Adults

Novo Nordisk's Wegovy Gets UK Approval as Preventative Treatment for Heart Problems in Obese, Overweight Adults

諾和諾德公司的Wegovy獲得了英國的批准,作爲預防肥胖和超重成年人心臟問題的治療。
MT Newswires ·  07/23 10:53

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論